Cancer Consortium Awards Six Pilot Grants
May 30, 2013 - Six pilot grants have been awarded by the Fred Hutchinson/University of Washington Cancer Consortium for 2013. The pilot grants are presented every year to fund new Consortium research directions and collaborations.
In a very competitive process and after careful consideration, the pilot committee chose six applications from among the 51 submitted. Each pilot grant is for $66,600 plus facilities and administrative costs.
The 2013 grants will support a diverse range of inquiries. They are:
- Joachim Deeg, MD (Clinical Resarch, FHCRC): Prevention of GVHD and Enhancement of GVT Effect by Alpha 1 Anti-trypsin
- Vivian Oehler, MD (Clinical Research, FHCRC): The genomics of primary myelofibrosis and its impact on megakaryocytes and fibrosis
- Doek-Ho Kim, PhD (UW Bioengineering) and Jonathan Cooper, PhD (Basic Sciences, FHCRC): Nano-mechanical matrix guidance cues and Rho signaling promotes cancer cell migration
- Linda Ko, PhD (Public Health Sciences, FHCRC): Cancer Communication within Social Networks
- Brian Iritani, DVM, PhD (UW Comparative Medicine): Regulation of cancer metabolism and tumor cell survival by Fnip1
- Oliver Press, MD, PhD (Clinical Research, FHCRC): Antibody-Targeted Nanoparticles for Lymphoma Treatment
In an era of tight National Institutes of Health funding, CCSG pilot grants are a particularly important mechanism supporting investigators as they gather critical data to substantiate a future NIH grant. The next CCSG Pilot competition will take place in early 2014.